February 21, 2018, Moscow – The Association of International Pharmaceutical Manufactures (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Director, Vasily Ignatiev, CEO, R-Pharm, has been elected Vice Chairman of the AIPM Board of Directors.
Previously the position of Vice Chairman of the AIPM Board of Directors was held by Vadim Vlasov, President of Novartis Group in Russia, Regional Director of Novartis for Eastern, Central Europe, and CIS. Since January of this year, Vadim Vlasov has chaired the Board of Directors of the Association.
“I really appreciate the trust the AIPM Board of Directors members put in me. I believe that the experience I gained while working at international innovative pharmaceutical manufacturers, as well as heading a large Russian pharmaceutical company that has taken its first important steps towards international markets, will be useful for the AIPM. Together with my colleagues, I hope to contribute to the achievement of the priority goals of the Association for development of the Russian innovative medicine market, the protection of intellectual property rights, and the improvement of legal regulations in the field of medicines’ circulation”, Vasily Ignatiev, R-Pharm CEO and Vice Chairman of the AIPM Board of Directors, noted.
“AIPM has constantly confirmed its commitment to the mission of extending the assortment of modern medicines available to the Russian patients, as well as the support of innovations and the proper protection of the rights to the results of intellectual activity. The decision of the AIPM Board of Directors was made in favor of the Russian company having high ambitions for innovation and fully sharing the values and priorities of the Association. In 2013, R-Pharm was the first company to receive the vote of confidence from the international pharmaceutical industry, becoming a member of AIPM. In this regard, the election of Vasily Ignatiev, initially as a member of Board of Directors and now as Vice Chairman of the Board of Directors of the Association, is a reasonable decision”, Vladimir Shipkov, AIPM Executive Director, has pointed out.
The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 and represents on the territory of the Russian Federation the leading international pharmaceutical companies – manufacturers and developers of modern effective, safe and high-quality medicines. AIPM brings together 60 international companies, which account for over 80% of world pharmaceutical production and more than 60% of the volume of medicines supplied to the Russian Federation.
For additional information, please contact
Legal and Communications Director, AIPM
+7 (495) 933 70 40,
Version for printing